|
1
|
Phase I clinical trial of CpG oligonucleotide 7909 (PF-03512676) in patients with previously treated chronic lymphocytic leukemia.
|
Leuk Lymphoma
|
2011
|
1.71
|
|
2
|
Addition of granulocyte macrophage colony stimulating factor does not improve response to early treatment of high-risk chronic lymphocytic leukemia with alemtuzumab and rituximab.
|
Leuk Lymphoma
|
2012
|
1.61
|
|
3
|
The prognostic significance of cytopenia in chronic lymphocytic leukaemia/small lymphocytic lymphoma.
|
Br J Haematol
|
2008
|
1.29
|
|
4
|
Direct and complement dependent cytotoxicity in CLL cells from patients with high-risk early-intermediate stage chronic lymphocytic leukemia (CLL) treated with alemtuzumab and rituximab.
|
Leuk Res
|
2008
|
1.03
|
|
5
|
Autoimmune cytopenia in chronic lymphocytic leukemia/small lymphocytic lymphoma: changes in clinical presentation and prognosis.
|
Leuk Lymphoma
|
2009
|
0.98
|
|
6
|
Management of patients with chronic lymphocytic leukemia with a high risk of adverse outcome: the Mayo Clinic approach.
|
Leuk Lymphoma
|
2011
|
0.90
|
|
7
|
Cell-mediated immunity in chronic lymphocytic leukemia.
|
Leuk Lymphoma
|
2010
|
0.84
|
|
8
|
Management of autoimmune cytopenia complicating chronic lymphocytic leukemia.
|
Leuk Lymphoma
|
2009
|
0.83
|
|
9
|
Update on monoclonal antibody therapy in chronic lymphocytic leukemia.
|
Clin Adv Hematol Oncol
|
2004
|
0.79
|
|
10
|
Detection of recurrent chromosomal defects in chronic lymphocytic leukemia/small lymphocytic lymphoma: innovations and applications.
|
Leuk Lymphoma
|
2010
|
0.75
|
|
11
|
Multi-parameter prognostication in chronic lymphocytic leukemia.
|
Leuk Lymphoma
|
2011
|
0.75
|
|
12
|
FISHing for answers in proliferation centers of chronic lymphocytic leukemia lymph nodes.
|
Leuk Lymphoma
|
2011
|
0.75
|
|
13
|
Improving quality of life in chronic lymphocytic leukemia.
|
Leuk Lymphoma
|
2012
|
0.75
|